As of 2025-09-19, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (250.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.29 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -4843.4%.
The range of the Relative Valuation is (153.72) - (299.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 11.4x | 9.5x |
| Forward P/E multiples | 5.8x - 11.3x | 9.5x |
| Fair Price | (153.72) - (299.52) | (250.92) |
| Upside | -3005.9% - -5762.1% | -4843.4% |
| Date | P/E |
| 2025-09-17 | -0.20 |
| 2025-09-16 | -0.19 |
| 2025-09-15 | -0.20 |
| 2025-09-12 | -0.20 |
| 2025-09-11 | -0.20 |
| 2025-09-10 | -0.20 |
| 2025-09-09 | -0.19 |
| 2025-09-08 | -0.19 |
| 2025-09-05 | -0.20 |
| 2025-09-04 | -0.18 |
| 2025-09-03 | -0.18 |
| 2025-09-02 | -0.19 |
| 2025-08-29 | -0.19 |
| 2025-08-28 | -0.20 |
| 2025-08-27 | -0.20 |
| 2025-08-26 | -0.20 |
| 2025-08-25 | -0.21 |
| 2025-08-22 | -0.19 |
| 2025-08-21 | -0.19 |
| 2025-08-20 | -0.18 |
| 2025-08-19 | -0.18 |
| 2025-08-18 | -0.19 |
| 2025-08-15 | -0.19 |
| 2025-08-14 | -0.21 |
| 2025-08-13 | -0.21 |
| 2025-08-12 | -0.21 |
| 2025-08-11 | -0.21 |
| 2025-08-08 | -0.21 |
| 2025-08-07 | -0.21 |
| 2025-08-06 | -0.21 |
| 2025-08-05 | -0.21 |
| 2025-08-04 | -0.21 |
| 2025-08-01 | -0.21 |
| 2025-07-31 | -0.21 |
| 2025-07-30 | -0.22 |
| 2025-07-29 | -0.23 |
| 2025-07-28 | -0.24 |
| 2025-07-25 | -0.24 |
| 2025-07-24 | -0.25 |
| 2025-07-23 | -0.25 |
| 2025-07-22 | -0.23 |
| 2025-07-21 | -0.22 |
| 2025-07-18 | -0.21 |
| 2025-07-17 | -0.22 |
| 2025-07-16 | -0.22 |
| 2025-07-15 | -0.21 |
| 2025-07-14 | -0.23 |
| 2025-07-11 | -0.23 |
| 2025-07-10 | -0.24 |
| 2025-07-09 | -0.24 |